Sign In

Adam Halbridge, MBA

Tokenization Lead & Executive Director at ICON plc

Adam Halbridge, MBA, is a Principal at PRA Health Sciences, currently leading Clinical Trial Tokenization operations and delivery at ICON plc. His professional background includes significant experience in the clinical research sector, focusing on innovative solutions for patient engagement and operational efficiency in clinical trials.

Education and Career

  • Education: He holds an MBA, which complements his expertise in managing clinical operations.
  • Current Role: As Principal at PRA Health Sciences, Halbridge is involved in enhancing clinical trial processes through tokenization and other technological advancements.

Professional Contributions

Halbridge is active on LinkedIn, where he shares insights on the importance of flexibility in clinical operations and engages with industry trends. He has participated in various conferences, such as #SCOPE2023 and #FOHD2023, where he discusses topics related to eClinical solutions and patient journey reimagining.124

Expertise

His work emphasizes the integration of real-world data and innovative methodologies to streamline clinical trials, aiming to improve patient outcomes and operational efficiencies within the pharmaceutical industry.35

Related Questions

What is Clinical Trial Tokenization?
How does Adam Halbridge contribute to ICON plc?
What are Adam Halbridge's key achievements at PRA Health Sciences?
What is the significance of the #scope2023 conference for Adam Halbridge?
How does Adam Halbridge's work at ICON impact the pharmaceutical industry?
Adam Halbridge, MBA
Adam Halbridge, MBA, photo 1
Adam Halbridge, MBA, photo 2
Add to my network

Location

San Diego, California, United States